...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Interesting Trades / Volume .....

, CD,

With upcoming top line results or full date release we could see a CVR deal with milestone payments that would protect both buyer and seller in the event that the FDA does not give full NDA acceptance . With good results and no safety issues Apabetalone could be a standard of care drug a major blockbuster, i would think a lot of BP would want to scoop RVX quickly IMO

Share
New Message
Please login to post a reply